Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort
- PMID: 35924579
- PMCID: PMC9713554
- DOI: 10.3324/haematol.2022.281431
Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort
Figures
References
-
- Benson MD, Buxbaum JN, Eisenberg DS, et al. . Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27(4):217-222. - PubMed
-
- Muchtar E, Dispenzieri A, Magen H, et al. . Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 2021;289(3):268-292. - PubMed
-
- Picken MM. The Pathology of amyloidosis in classification: a review. Acta Haematol. 2020;143(4):322-334. - PubMed
-
- Gonzalez Suarez ML, Zhang P, Nasr SH, et al. . The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry. Kidney Int. 2019;96(4):1005-1009. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
